Thromboembolic and cardiovascular risk profiles in patients with ulcerative colitis initiating advanced therapies
In our cohort, both thromboembolic and CV risks were overall low. CV risk was higher in elderly patients. The incidence of VTE and CV events during follow-up was low. These findings suggest that concerns regarding the intrinsic VTE and CV risks associated with Janus kinase inhibitors may not fully apply to UC patients.
Authors
- Luigi Carbone (ORCID: https://orcid.org/0000-0002-1415-3310)
- Giuseppe Cuccia (ORCID: https://orcid.org/0009-0004-8766-5108)
- L Parisio (ORCID: https://orcid.org/0000-0001-8481-4164)
- Giuseppe Privitera
- Franco Scaldaferri (ORCID: https://orcid.org/0000-0001-8334-7541)
- Ivan Capobianco (ORCID: https://orcid.org/0000-0003-3927-591X)
- Angelo Del Gaudio (ORCID: https://orcid.org/0009-0003-9356-5093)
- Daniela Pugliese (ORCID: https://orcid.org/0000-0001-7930-5402)
- Antonio Gasbarrini (ORCID: https://orcid.org/0000-0003-4863-6924)
- Valentin Calvez (ORCID: https://orcid.org/0009-0007-2528-8337)
Institutions
- Università Cattolica del Sacro Cuore (IT)
- Humanitas University (IT)
- Agostino Gemelli University Polyclinic (IT)
- Centro Clinico Nemo (IT)
Publication Details
- Journal
- Therapeutic Advances in Gastroenterology
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1177/17562848251388355
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00